![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, March 03, 2014 2:27:41 PM
Apart from data announcements on MCC and Mel trials, I eagerly anticipate the Anti-Pd-1 + Immunopulse combo trial; This will be a true breakthrough.
I wonder if the new non-cutaneous tumor trial will be the one to involve anti-pd-1s.
Would an anti-pd-1 trial be pending partnership? (Punit stated a month ago that we're looking for an anti-pd-1 partner). If the new new non-cutaneous tumor trial does indeed involve Anti-Pd-1s, does this then mean that we're near finalization of a partnership?? Maybe. Maybe not.
We'll see.
Either way, great things ahead/
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
FEATURED Mawson Finland Limited Expands Known Mineralized Zones at Rajapalot: New Lens Intercepts 21.75 m at 5.25 g/t Gold & 515 ppm Cobalt • Sep 4, 2024 9:02 AM
FEATURED Integrated Ventures Acquires 51% Stake In GetTrim.Com (TM), Telemedicine Platform With Focus On Expansion Into Booming GLP-1 Powered Weight Loss Market • Sep 4, 2024 8:45 AM
VAYK Confirms Receiving Revenue from First Airbnb Property with 1.4 Million Annual Revenue Goal • VAYK • Sep 4, 2024 9:34 AM
Avant Technologies Announces Strategic Review Process Intended to Maximize Shareholder Value • AVAI • Sep 4, 2024 8:00 AM
PickleJar Launches National "Get on the Bus" Campaign, Unveils Thompson Square Tour Bus Wrap • PKLE • Sep 4, 2024 7:17 AM
Maybacks Global and Inventel Products To Launch Global 24 Hour Shopping Channel • AHRO • Sep 3, 2024 9:15 AM